DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Ma R, Chen J, Liang Y. , et al.
Sorafenib: A potential therapeutic drug for hepatic fibrosis and its outcomes.
Biomed Pharmacother 2017;
88: 459-468
We do not assume any responsibility for the contents of the web pages of other providers.